Perspective and Highlights from the 27th Annual Miami Breast Cancer Conference
Over the past decade, the oncology community has made significant progress in the development of highly effective treatment modalities for breast cancer. Moreover, our increasing knowledge of the molecular biology of cancer has engendered the potential to use gene expression profiling, molecular fingerprinting, and biomarkers to add increased, patient-specific value to our clinical decision making. More than ever, today’s clinician must keep up to date on the rapid scientific advances in breast cancer management.